1. Home
  2. ZLAB vs CLM Comparison

ZLAB vs CLM Comparison

Compare ZLAB & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.40

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Cornerstone Strategic Value Fund Inc. New

CLM

Cornerstone Strategic Value Fund Inc. New

HOLD

Current Price

$7.49

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
CLM
Founded
2013
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2017
1995

Fundamental Metrics

Financial Performance
Metric
ZLAB
CLM
Price
$18.40
$7.49
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$49.60
N/A
AVG Volume (30 Days)
867.0K
1.4M
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
38.46
N/A
EPS
N/A
N/A
Revenue
$460,156,000.00
N/A
Revenue This Year
$9.75
N/A
Revenue Next Year
$26.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.33
N/A
52 Week Low
$15.96
$6.92
52 Week High
$41.20
$8.53

Technical Indicators

Market Signals
Indicator
ZLAB
CLM
Relative Strength Index (RSI) 52.14 46.18
Support Level $18.29 $7.33
Resistance Level $19.49 $7.79
Average True Range (ATR) 0.65 0.10
MACD 0.23 -0.02
Stochastic Oscillator 77.19 32.76

Price Performance

Historical Comparison
ZLAB
CLM

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About CLM Cornerstone Strategic Value Fund Inc. New

Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, Consumer Staples, utilities, energy, Real Estate, materials, and other sectors.

Share on Social Networks: